NO914986D0 - Fremgangsmaate for fremstilling av anti-herpescastanosperminestere - Google Patents

Fremgangsmaate for fremstilling av anti-herpescastanosperminestere

Info

Publication number
NO914986D0
NO914986D0 NO914986A NO914986A NO914986D0 NO 914986 D0 NO914986 D0 NO 914986D0 NO 914986 A NO914986 A NO 914986A NO 914986 A NO914986 A NO 914986A NO 914986 D0 NO914986 D0 NO 914986D0
Authority
NO
Norway
Prior art keywords
herpescastanosperminesters
procedure
manufacturing
active
treatment
Prior art date
Application number
NO914986A
Other languages
English (en)
Inventor
Albert Stanley Tyms
Paul Saiho Liu
Debra Lynn Taylor
Sai Prasad Sunkara
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO914986D0 publication Critical patent/NO914986D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)
NO914986A 1990-12-18 1991-12-17 Fremgangsmaate for fremstilling av anti-herpescastanosperminestere NO914986D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027433A GB9027433D0 (en) 1990-12-18 1990-12-18 Anti-herpes castanospermine esters

Publications (1)

Publication Number Publication Date
NO914986D0 true NO914986D0 (no) 1991-12-17

Family

ID=10687190

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914986A NO914986D0 (no) 1990-12-18 1991-12-17 Fremgangsmaate for fremstilling av anti-herpescastanosperminestere

Country Status (20)

Country Link
US (1) US5385911A (no)
EP (1) EP0492841B1 (no)
JP (1) JPH04342587A (no)
KR (1) KR100192642B1 (no)
AT (1) ATE126435T1 (no)
AU (1) AU643098B2 (no)
CA (1) CA2057821A1 (no)
DE (1) DE69112192T2 (no)
DK (1) DK0492841T3 (no)
ES (1) ES2078462T3 (no)
FI (1) FI915929A (no)
GB (1) GB9027433D0 (no)
GR (1) GR3017152T3 (no)
HU (1) HU210257B (no)
IE (1) IE914400A1 (no)
IL (1) IL100233A (no)
NO (1) NO914986D0 (no)
NZ (1) NZ240976A (no)
PT (1) PT99835B (no)
ZA (1) ZA919808B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466714A (en) * 1987-12-31 1995-11-14 Research Foundation For Mental Health Hygiene, Inc. Spermicidal and cytocidal fatty acid compositions
US5959111A (en) * 1997-05-22 1999-09-28 Hoechst Marion Roussel, Inc. Process for preparing 6-0-monoesters of castanospermine
WO2001054692A1 (en) * 2000-01-28 2001-08-02 Synergy Pharmaceuticals, Inc. Use of castanospermine and substituted-castanospermine compounds for treating hepatitis virus infections
GB0110832D0 (en) * 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
GB0116643D0 (en) * 2001-07-09 2001-08-29 Virogen Ltd Antiviral compounds
US7930711B2 (en) * 2003-03-06 2011-04-19 Wegener Communications, Inc. Apparatus and method for addressing control in a network for distributed data
KR20070061879A (ko) * 2004-10-06 2007-06-14 미게닉스 인코포레이티드 카스타노스페르민을 포함하는 조합 항-바이러스 조성물 및그의 사용 방법
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
JP2009545621A (ja) * 2006-08-02 2009-12-24 ユナイテッド セラピューティクス コーポレーション ウィルス感染症のリポソーム処置
CA2719567A1 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
CN102427804A (zh) * 2009-03-27 2012-04-25 牛津大学之校长及学者 降低胆固醇水平的脂质体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760079A (en) * 1983-01-10 1988-07-26 Baltech, Inc. Treatment of diseases caused by herpes viruses
US4628063A (en) * 1984-03-08 1986-12-09 Dana P. Brigham Antiviral pharmaceutical preparations and methods for their use
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
JPS61227566A (ja) * 1985-04-01 1986-10-09 Fujisawa Pharmaceut Co Ltd スワインソニンおよび関連化合物の合成法
US4751236A (en) * 1987-05-20 1988-06-14 Avihou Mishniot Method for treating genital herpes
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
US5017563A (en) * 1988-06-23 1991-05-21 Merrell Dow Pharmaceuticals Inc. Castanospermine esters and glycosides

Also Published As

Publication number Publication date
ES2078462T3 (es) 1995-12-16
FI915929A (fi) 1992-06-19
DE69112192D1 (de) 1995-09-21
KR920011488A (ko) 1992-07-24
FI915929A0 (fi) 1991-12-17
EP0492841B1 (en) 1995-08-16
PT99835A (pt) 1992-12-31
IL100233A0 (en) 1992-09-06
US5385911A (en) 1995-01-31
HU913989D0 (en) 1992-03-30
GB9027433D0 (en) 1991-02-06
DK0492841T3 (da) 1995-09-18
JPH04342587A (ja) 1992-11-30
AU643098B2 (en) 1993-11-04
DE69112192T2 (de) 1996-04-04
ZA919808B (en) 1992-09-30
IE914400A1 (en) 1992-07-01
ATE126435T1 (de) 1995-09-15
KR100192642B1 (ko) 1999-06-15
CA2057821A1 (en) 1992-06-19
EP0492841A1 (en) 1992-07-01
HU210257B (en) 1995-03-28
AU8964191A (en) 1992-06-25
PT99835B (pt) 1999-06-30
HUT59924A (en) 1992-07-28
IL100233A (en) 1996-03-31
NZ240976A (en) 1997-03-24
GR3017152T3 (en) 1995-11-30

Similar Documents

Publication Publication Date Title
FI915844A0 (fi) Nya dihydro-isokinolinderivat.
NO912672L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oligomerer.
FI913142A (fi) Migraenfoerhindrande alkoxipyrimidinderivat.
NO914986D0 (no) Fremgangsmaate for fremstilling av anti-herpescastanosperminestere
ES2061609T3 (es) 2',3'-dideoxi-2'-fluoro-nucleosidos.
DE68920011D1 (de) Optische halbleiteranordung und deren herstellung.
EP0235589A3 (en) Use of quinolone and naphthyridine antibiotics for the manufacture of ophthalmic medicaments
NO175714C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, aromatiske estere
DE69116705D1 (de) Antiglancoma-Zusammensetzungen enthaltend 3-Arylcarbonyl-1-aminoalkyl-1H-indol
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
NO914071D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
NO304428B1 (no) AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler
FI851365L (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
FI950010A (fi) Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
NO903796L (no) Fremgangsmaate for fremstilling av optisk aktive epoksyder.
SE8604669D0 (sv) Medel for behandling av svampinfektioner i naglar
FI925209A0 (fi) Foerfarande foer framstaellning av terapeutiskt aktiva heterocykliskt substituerade foereningar
NO924316L (no) Fremgangsmaate for fremstilling av optisk aktive 1,4-dioler